We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-13.16%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.2B
AUM Growth
-$730M
Cap. Flow
-$164M
Cap. Flow %
-5.14%
Top 10 Hldgs %
14.44%
Holding
1,433
New
85
Increased
447
Reduced
621
Closed
196

Top Buys

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$7.65M
2
VZ icon
Verizon
VZ
+$4.92M
3
LIN icon
Linde
LIN
+$4.78M
4
ILMN icon
Illumina
ILMN
+$4.5M
5
AAPL icon
Apple
AAPL
+$4.21M

Sector Composition

Rank Sector Weight
1 Healthcare 13.46%
2 Technology 12.76%
3 Financials 11.37%
4 Industrials 8.31%
5 Consumer Discretionary 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COP icon
151
ConocoPhillips
COP
$141B
$4.71M 0.15%
75,555
+3,629
+5% +$247K
AGG icon
152
iShares Core US Aggregate Bond ETF
AGG
$138B
$4.68M 0.15%
43,916
+7,436
+20% +$780K
PPL
153
PPL Corp
PPL
$26.7B
$4.62M 0.14%
162,997
+4,412
+3% +$134K
CI icon
154
Cigna
CI
$74.6B
$4.6M 0.14%
24,232
+7,641
+46% +$1.59M
PRU icon
155
Prudential Financial
PRU
$41.8B
$4.57M 0.14%
56,020
-1,767
-3% -$163K
NOBL icon
156
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
$4.56M 0.14%
150,548
+33,900
+29% +$1.08M
MET icon
157
MetLife
MET
$62.1B
$4.53M 0.14%
110,351
-6,488
-6% -$278K
DGX icon
158
Quest Diagnostics
DGX
$26.3B
$4.52M 0.14%
54,286
+1,638
+3% +$154K
KMI icon
159
Kinder Morgan
KMI
$68.7B
$4.5M 0.14%
292,863
-39,483
-12% -$668K
IHI icon
160
iShares US Medical Devices ETF
IHI
$3.37B
$4.48M 0.14%
134,442
-16,968
-11% -$588K
XLNX
161
DELISTED
Xilinx Inc
XLNX
$4.47M 0.14%
52,496
-3,742
-7% -$313K
CHKP icon
162
Check Point Software Technologies
CHKP
$13.1B
$4.46M 0.14%
43,420
-1,411
-3% -$155K
LHX icon
163
L3Harris
LHX
$53.4B
$4.46M 0.14%
33,101
-8,122
-20% -$1.23M
BF.B icon
164
Brown-Forman Class B
BF.B
$13.1B
$4.37M 0.14%
91,832
-468
-0.5% -$22.2K
OLED icon
165
Universal Display
OLED
$4.19B
$4.32M 0.14%
46,205
-870
-2% -$87.8K
AVGO icon
166
Broadcom
AVGO
$2.04T
$4.32M 0.14%
169,820
+9,240
+6% +$218K
APD icon
167
Air Products & Chemicals
APD
$67.6B
$4.31M 0.13%
26,939
+774
+3% +$123K
BCE icon
168
BCE
BCE
$21.2B
$4.31M 0.13%
108,942
+2,113
+2% +$86.5K
VTI icon
169
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
$4.3M 0.13%
33,717
+14,137
+72% +$1.95M
BVN icon
170
Compañía de Minas Buenaventura
BVN
$8.67B
$4.28M 0.13%
264,027
-790
-0.3% -$11.4K
ITA icon
171
iShares US Aerospace & Defense ETF
ITA
$15B
$4.27M 0.13%
49,460
-8,312
-14% -$801K
VLO icon
172
Valero Energy
VLO
$85.9B
$4.26M 0.13%
56,893
+5,171
+10% +$454K
FUN icon
173
Cedar Fair
FUN
$1.67B
$4.24M 0.13%
89,555
+36,572
+69% +$1.91M
O icon
174
Realty Income
O
$59.1B
$4.22M 0.13%
69,013
-4,948
-7% -$295K
HA
175
DELISTED
Hawaiian Holdings, Inc.
HA
$4.19M 0.13%
158,770
-61,741
-28% -$2.09M

Similar funds

Oppenheimer & Co's Q4 2018 Portfolio in Review

As of Q4 2018, Oppenheimer & Co held 1,433 positions worth $3.2B, down 19% from $3.93B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co withdrew a net $164M in Q4 2018, closing 196 positions and reducing 621 holdings. Its most notable exit was Etsy, an estimated $6.87M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

Against the trend, Oppenheimer & Co opened a new position in Linde worth $4.72M.

  • Oppenheimer & Co's largest Q4 2018 buy was Linde: 30,256 shares worth $4.72M.
  • Oppenheimer & Co added most to iShares 20+ Year Treasury Bond ETF in Q4 2018, an estimated $7.65M increase.
  • Oppenheimer & Co's biggest Q4 2018 reduction was Meta Platforms (Facebook), cutting an estimated $9.23M.
  • Oppenheimer & Co fully exited Etsy in Q4 2018, selling an estimated $6.87M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.2B portfolio in Q4 2018.
  • Oppenheimer & Co opened 85 new positions and closed 196 in Q4 2018.
  • Oppenheimer & Co's portfolio value fell 19% quarter-over-quarter to $3.2B.

Based on Oppenheimer & Co's 13F filing for Q4 2018, filed 29 Jan 2019.